Global Markets Direct's, 'Diabetology Limited - Product Pipeline Review - 2014', provides an overview of the Diabetology Limited's pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Diabetology Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Full Report Details at
- http://www.fastmr.com/prod/906403_diabetology_limited_product_pipeline_review_2014.aspx?afid=101
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
* The report provides brief overview of Diabetology Limited including business description, key information and facts, and its locations and subsidiaries
* The report reviews current pipeline of Diabetology Limited's human therapeutic division and enlists all their major and minor projects
* The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
* Special feature on out-licensed and partnered product portfolio
* The report summarizes all the dormant and discontinued pipeline projects
* Latest company statement
* Latest news and deals relating to the Diabetology Limited's pipeline products
Reasons to Get this Report
* Evaluate Diabetology Limited's strategic position with total access to detailed information on its product pipeline
* Assess the growth potential of Diabetology Limited in its therapy areas of focus
* Identify new drug targets and therapeutic classes in the Diabetology Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
* Develop strategic initiatives by understanding the focus areas of Diabetology Limited and exploit collaboration and partnership opportunities
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Plan mergers and acquisitions effectively by identifying the most promising pipeline of Diabetology Limited
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Explore the dormant and discontinued projects of Diabetology Limited and identify potential opportunities in those areas
* Avoid Intellectual Property Rights related issues
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
Diabetology Limited Snapshot
Diabetology Limited Overview
Key Information
Key Facts
Diabetology Limited - Research and Development Overview
Key Therapeutic Areas
Diabetology Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Diabetology Limited - Pipeline Products Glance
Diabetology Limited - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Diabetology Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Diabetology Limited - Drug Profiles
Capsulin OAD
Product Description
Mechanism of Action
R&D Progress
insulin human
Product Description
Mechanism of Action
R&D Progress
Combulin
Product Description
Mechanism of Action
R&D Progress
Oral C-Peptide Analogs
Product Description
Mechanism of Action
R&D Progress
Oral GLP-1
Product Description
Mechanism of Action
R&D Progress
Oral GLP-1 Analogs
Product Description
Mechanism of Action
R&D Progress
Oral Insulin Analogs
Product Description
Mechanism of Action
R&D Progress
Diabetology Limited - Pipeline Analysis
Diabetology Limited - Pipeline Products by Target
Diabetology Limited - Pipeline Products by Route of Administration
Diabetology Limited - Pipeline Products by Molecule Type
Diabetology Limited - Pipeline Products by Mechanism of Action
Diabetology Limited - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Diabetology Limited, Key Information
Diabetology Limited, Key Facts
Diabetology Limited - Pipeline by Indication, 2014
Diabetology Limited - Pipeline by Stage of Development, 2014
Diabetology Limited - Monotherapy Products in Pipeline, 2014
Diabetology Limited - Phase II, 2014
Diabetology Limited - Preclinical, 2014
Diabetology Limited - Pipeline by Target, 2014
Diabetology Limited - Pipeline by Route of Administration, 2014
Diabetology Limited - Pipeline by Molecule Type, 2014
Full Table of Contents is available at:
-- http://www.fastmr.com/prod/906403_diabetology_limited_product_pipeline_review_2014.aspx?dt=t&afid=101
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
read full article